According to the Pew Charitable Trusts, more than $27 billion was spent on marketing to physicians by the pharmaceutical industry in the year 2012.
The Food and Drug Administration recently banned 3 chemicals used in food packaging, and 8 more food additives are on the chopping block.
Genetically modified tree-creator ArborGen has been fined $53.5 million in compensation and punitive damages for defrauding its employees.
A top federal bee scientist is being punished by the USDA for publicizing ‘honest work’ on pesticides and pollinators, though a judge ruled in his favor.
Monsanto’s plans to construct a $90 million GM corn processing plant in Independence, Iowa have reportedly been scrapped due to a ‘struggling farm economy.’
Marijuana possession in any amount is considered a minor misdemeanor now in Toledo, Ohio, keeping more non-criminals out of jail.
USDA Secretary of Agriculture Tom Vilsack has announced a closed-door, invitation-only meeting to continue the bidding of the biotech industry.
The city of Berkeley, California has decided to hold Monsanto legally liable for polluting the land and water with PCBs (polychlorinated biphenyls).
There are more than 22,000 nurses, part of Nurses against Mandatory Vaccines (NAMV), who are refusing mandatory vaccines.
Senator Debbie Stabenow has been working overtime to make sure that biotech wins in passing GMO labeling legislation.
The EPA has missed its own risk assessment deadline in 2015 for the toxic pesticides atrazine, glyphosate, and imidacloprid.
Dow Chemical and DuPont are to merge under a $130 billion deal, only to split into 3 independently-traded companies.
Biotech giant Monsanto has revealed that it will be cutting a total of 3,600 jobs due to restructuring and falling sales of its herbicide chemicals.
With the help of activists and environmentalists, groundfish that were dying off fast are now returning to the West Coast.
Researchers have found alarming levels of mercury in the fog that sometimes surrounds the Golden Gate bridge, harming the ecosystem and human health.
In December, 2015, the Swiss Federal Council decided to extend the country’s moratorium on the cultivation of GM seed until at least 2021.
GW Pharmaceuticals is expected to be given a green light for a cannabidiol drug (marijuana-based medicine) which shows promise in treating epilepsy.